PAR-23-269 - NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
On This Page: 4
Active NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|---|---|---|---|---|
Notice of Special Interest (NOSI): Targeting the Endocannabinoid System for Brain Health and Acute and Chronic Diseases | NOT-DA-22-048 | NIDA , NCI , NIDCR | Jan 9, 2023 | Jan 8, 2026 | R01, R21, DP2, DP1, K99/R00, K01, R36, K08, R15, K24 |
Expired NOSIs
Title | Notice Number | Organization | Release Date |
Expiration Date |
Activity Code(s) |
---|---|---|---|---|---|
Notice of Special Interest (NOSI): Reducing Stigma Related to Drug Use in Human Service Settings | NOT-DA-21-060 | NIDA NIMH | Nov 18, 2021 | Jan 8, 2025 | R34, R01, DP1, DP2 |
Notice of Special Interest (NOSI): Advancing HIV/AIDS Research through Computational Neuroscience | NOT-DA-21-030 | NIDA | Jun 22, 2021 | Jan 8, 2025 | R01, R21, R03, DP2, DP1, K99/R00, K01, R36, P01, R15, K24 |
Notice of Special Interest (NOSI): Identification of Biomarkers of HIV Pathogenesis and Substance Use Disorder Comorbidity | NOT-DA-21-014 | NIDA | Mar 31, 2021 | Sep 8, 2024 | R01, R21, DP2, DP1, K99/R00, K01, R36, P01, R15, K24 |